4processed
Form 4 — Insider Transaction
Lexeo Therapeutics, Inc.(LXEO)
Filing Date
June 29, 2026
Accepted
June 29, 2026
Accession No.
0001995218-26-000013
CIK
0001907108
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Townsend Richard Nolan | Chief Executive Officer | Other | 67.0K | $0 | — | 403.8K | Common Stock | Jun 29, 2026 |
| Townsend Richard Nolan | Chief Executive Officer | Other | 25.9K | $4.48 | — | 377.8K | Common Stock | Jul 1, 2026 |